The FDA announced late yesterday that a new warning will be added to the schizophrenia drug Haldol, indicating that users could face an increased risk of sudden death from dangerous heart conditions. Haldol side effects have been associated with sudden death, QT prolongation and Torsades de… Read More
By Harvey Kirk
September 18, 2007 | 1 Comment
An FDA advisory panel met last week and found that a Trasylol recall is not warranted at this time, despite evidence that suggests the drug may increase the risk of kidney failure, heart failure, stroke and death. The recommendation was made after the panel of experts… Read More
By Harvey Kirk
September 17, 2007 | No Comments
According to warnings posted yesterday by the FDA, Fentora has been linked to several deaths caused by fentanyl overdose. Fentora is a newer medication, similar to the Actiq lollipop, which is only approved for use in cancer patients who have breakthrough pain not managed by other… Read More
By Harvey Kirk
September 14, 2007 | 4 Comments
According to FDA staff members, a heart bypass surgery injection known as Trasylol (aprotonin), appears to increase the risk of kidney failure, heart attacks, strokes and death. The statement was yesterday in advance of an advisory panel meeting scheduled to begin tomorrow. >>INFORMATION: Heart Bypass Surgery… Read More
By Harvey Kirk
September 11, 2007 | No Comments
Concerned by reports of fentanyl patch overdoses and deaths, the Institute of Safe Medicine Practices issued recommendations to reduce the dangers of fentanyl patch problems. Misinformed and careless physicians continue to prescribe the pain patch inappropriately, with doses that are too large or in combination with… Read More
By Harvey Kirk
September 4, 2007 | 2 Comments
According to an article in the Los Angeles Times, the degree of danger associated with the Duragesic fentanyl skin patch is still not fully appreciated by healthcare providers and deaths continue to occur at an alarming rate as a result of sudden fentanyl overdose for unsuspecting… Read More
By Harvey Kirk
August 28, 2007 | No Comments
The FDA will hold a second advisory panel meeting on September 12, 2007 to review the safety of Bayer AG's heart surgery aprotonin injection, marketed as Trasylol. Following a prior meeting of experts in September 2006, regulators decided against a Trasylol recall and instead decided to… Read More
By Harvey Kirk
August 24, 2007 | No Comments
A new FDA warning indicates that codeine side effects could result in a morphine overdose for nursing babies when the drug is taken by a breastfeeding mother who is an ultra-fast metabolizer of codeine. (more…) Read More
By Harvey Kirk
August 21, 2007 | No Comments
The FDA announced late yesterday that the manufacturers of Avandia and Actos have agreed to add a stronger black box warning regarding the increased risk of heart failure. The announcement comes two months after federal regulators testified at a congressional hearing that they would be requesting… Read More
By Harvey Kirk
August 15, 2007 | 2 Comments
Sales of drug eluting stents have fallen over the past year, following reports in October 2006 that the small devices could increase the risk of blood clots which develop months or even years after it is implanted. Doctors throughout the United States have not been as… Read More
By Harvey Kirk
August 9, 2007 | No Comments